Publication
Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.
Journal Paper/Review - Apr 15, 2022
Rüfenacht Susanne, Gantenbein Pascal, Boggian Katia, Flury Domenica, Kern Lukas, Dollenmaier Günter, Kohler Philipp, Albrich Werner C
Units
PubMed
Doi
Contact
Citation
Type
Journal
Publication Date
Issn Electronic
Pages
Brief description/objective
COVID-19 patients on anti-CD20 treatment can suffer a delayed viral clearance and worse clinical outcome. We aim to present our experience with remdesivir treatment in anti-CD20-treated patients with prolonged symptoms, a patient population for which no data from randomized controlled trials are available.